Immuno-Oncology Research
Explore expression of your immuno-oncology biomarker in the context of tumor immune microenvironment using pathologist reviewed tissues & TMAs selected specifically for immuno-oncology projects.
TriStar offers a range TMAs (multi-tumor & tumor-specific) designed specifically for immuno-oncology projects with donors represented by cores taken from invasive margin and tumor center, created from FFPE blocks with associated TIL assessment (high/moderate/low) and PD-L1 scores (22C3).
Generate and compare immune profiles across multiple tumor types using established & optimized immune biomarker assays. Analyze tissues with extensive SOC & CKI clinical follow up information to integrate tumor immune profiles with treatment response & resistance.
Benefits of choosing Tristar’s services
TMAs
TMAs designed for immuno-oncology projects with added immune cell infiltration data available, plus optional RNAseq data & 2nd line CKI treatment and response information.
Immune biomarker assays
Optimized assays for immune cell populations and pathologist/digital image analysis solutions for enumeration.
Service Workflow
Define Your Project Requirements
We will sit down with you and work out exactly what the objective of your project is as well as the parameters to work within.
Sample Allocation
We will source the right samples from within our repositories and network.
Services Platform
We will put together the right team and platforms to complete your project correctly and on time.
